中文版   English

Product Center

    AristaTM Surgical Hemostatic Device

    Approval Number: GuoShiYaoJianXie (Jin) 2005 No. 3641501 Product Introduction: The products are imported with original packing from America and approved by European Union CE, American Food and Drug Administration and China State Food and Drug Administration. Micropomus polysaccharide particles are the only composition in AristaTM Surgical Hemostatic Device. The spherical and elastic particles with thousands of micropomus on the surface and a diameter of 100μm are produced after 28 days’ emulsification cross-linking process of the polysaccharide prepared from purified of plant starch. It has double hemostatic mechanism. It entered China’s market in 2006, the marker is mature. It is the most advanced top hemostatic agent in the country.

Product Features; powerful and quick-acting hemostasis, complete hydrolysis and enzymolysis, preventing adhesion after operation, reducing drainage after operation, preventing infection after operation, accelerating concrescence of tissue, easy to operate and covering all departments of the surgery.